| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89f5d58e2663876d21fe9f528bd2e287 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2004-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29b40df4f984354999646d231cc904ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_512cb4a66f817d886b5ec22e48861178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04f9a70168b6931d4b036cc4e408b390
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0863ca94f57addc7366288556d7c75e6 |
| publicationDate |
2004-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004166067-A1 |
| titleOfInvention |
Pharmaceutical compositions |
| abstract |
This invention provides a composition for the intranasal delivery of fentanyl or a pharmaceutically acceptable salt thereof to an animal comprising an aqueous solution of fentanyl or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable additive selected from (i) a pectin and (ii) a poloxamer and chitosan or a salt or derivative thereof; provided that when the composition comprises a pectin it is substantially free of divalent metal ions; and which, in comparison to a simple aqueous solution of fentanyl administered intranasally at the same dose, provides a peak plasma concentration of fentanyl (C max ) that is from 10 to 80% of that achieved using a simple aqueous solution of fentanyl administered intranasally at an identical fentanyl dose. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007134164-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9078814-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8653107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004034059-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011105551-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8017627-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9814705-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8158651-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889176-B2 |
| priorityDate |
2003-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |